Fierce Pharma

MAY 22, 2023

Pfizer, Moderna among many biopharma giants to post Q1 sales declines, as Novo Nordisk led growth charge kdunleavy Mon, 05/22/2023 - 13:04

Biopharma 256

Biopharma Sales 256

Fierce Pharma

MARCH 21, 2023

Biopharma industry lobbies for tax breaks related to US-based manufacturing kdunleavy Tue, 03/21/2023 - 11:14

Biopharma 237

Biopharma Manufacturing 237

MedCity News

OCTOBER 3, 2023

Acquiring Point Biopharma gives Eli Lilly a pipeline of radiopharmaceuticals, including one for prostate cancer that could rival Novartis’s Pluvicto. The deal comes ahead of an expected Phase 3 data readout for that Point therapeutic candidate.

Biopharma 109

Biopharma Pharma 109

Fierce Pharma

MAY 9, 2023

Let's make a deal: Conditions are right for biopharma M&A to break out, analysts say kdunleavy Tue, 05/09/2023 - 10:18

Biopharma 201

Biopharma 201

Fierce Pharma

DECEMBER 20, 2022

2023 forecast: An 'inflection point' for biopharma, fueled by a flood of AI and machine learning products. Tue, 12/20/2022 - 13:39.

Biopharma 241

Biopharma 241

PharmaTech

NOVEMBER 3, 2023

Pharmaceutical Technology Europe® spoke with Gustavo Ferrer from Dr. Ferrer BioPharma, a US company focused on innovative intranasal medications, at the inaugural Start-Up Market on the show floor at CPHI Barcelona 2023.

Biopharma 98

Biopharma Pharmaceutical Medical Marketing 98

Fierce Pharma

MAY 9, 2023

We want your stories: Biopharma's collective memory of COVID—in photographs aliu Tue, 05/09/2023 - 14:56

Biopharma 162

Biopharma 162

Fierce Pharma

MAY 25, 2023

The Top Line': The 20 most influential people in biopharma, plus this week's headlines tcarey Thu, 05/25/2023 - 14:21

Biopharma 172

Biopharma 172

Fierce Pharma

DECEMBER 21, 2022

Tamiflu generics in short supply in latest chapter of biopharma's shortage saga. fkansteiner. Wed, 12/21/2022 - 08:40.

Biopharma 188

Biopharma 188

PharmExec

AUGUST 21, 2023

In this exclusive Q&A with Pharmaceutical Executive, Janice Chang, CEO of TransCelerate BioPharma, provides an inside look into her career journey, her work at the company, how the industry has changed in the last 10 years, as well as her thoughts on where the industry should put its efforts in clinical trials.

Biopharma 97

Biopharma Pharmaceutical 97

Fierce Pharma

APRIL 19, 2023

Alnylam, Intra-Cellular among analyst's top picks for M&A as biopharma dealmaking heats up aliu Wed, 04/19/2023 - 14:39

Biopharma 178

Biopharma 178

Fierce Pharma

MAY 18, 2023

The Top Line': 2023's biopharma layoffs, plus this week's headlines tcarey Thu, 05/18/2023 - 16:13

Biopharma 147

Biopharma 147

MedCity News

AUGUST 21, 2023

Healthcare M&A deals are expected to pick up over the next few months, and one expert is predicting that the biopharma sector in particular will see especially robust activity.

Biopharma 91

Biopharma Marketing Healthcare Healthcare 91

European Pharmaceutical Review

SEPTEMBER 4, 2023

The biopharma company will be required to seek prior approval before acquiring related products. Divest to invest: the new normal in biopharma? The post FTC order could ease biopharma competition appeared first on European Pharmaceutical Review. The FTC has settled on a proposed consent order with Amgen Inc.

Biopharma 73

Biopharma Competition Pharmaceutical Medicine 73

PharmaVoice

JUNE 13, 2023

Collaboration is important along the entire spectrum and lifecycle of biopharma, and finding an effective partner is harder than it sounds.

Biopharma 105

Biopharma 105

Fierce Pharma

NOVEMBER 27, 2023

Following similar campaigns mounted by industry players and biopharma trade groups, the United States' Solicitor General has joined a chorus of voices calling on the Supreme Court to overturn an ap | Following similar campaigns mounted by industry players and biopharma trade groups, the United States' Solicitor General has joined a chorus (..)

Biopharma 245

Biopharma 245

PharmExec

JULY 26, 2023

As we approach the one-year anniversary of the IRA being signed into law, questions remain about how the new law will reverberate changes across the biopharma industry.

Biopharma 98

Biopharma 98

PharmaTech

OCTOBER 19, 2023

In this episode of the Drug Solutions Podcast, industry experts discuss the challenges and advantages of the digitalization trend in the biopharma industry, with particular emphasis on the impacts to biomanufacturing.

Biopharma 75

Biopharma 75

European Pharmaceutical Review

APRIL 17, 2023

A report on automation in the biopharma industr y has shown that the market is projected to grow at a compound annual growth rate (CAGR) of 5.7 Factors impacting the automation in the biopharma industry market The report found that 75 percent of pharmaceutical organisations want to use automated solutions more frequently.

Biopharma 82

Biopharma Pharmaceutical Pharmaceutical products Manufacturing 82

European Pharmaceutical Review

JUNE 7, 2023

The global biopharma industry’s resilience has decreased since 2021, a report by Cytiva has found. Using feedback from 1250 pharma and biopharma executives in 22 countries, the research sought to find out how has the biopharma industry has evolved over the past two years and what areas the industry should seek to improve.

Biopharma 69

Biopharma Pharma Manufacturing Government 69

Pharmaceutical Technology

DECEMBER 4, 2023

GC Biopharma has concluded the construction activities at an mRNA manufacturing plant at its vaccine production site in South Korea.

Biopharma 52

Biopharma Manufacturing 52

European Pharmaceutical Review

JULY 7, 2023

New recommendations to boost the competitiveness in UK biopharma and Medtech sectors have been published by Imperial College London. Technological solutions and policy recommendations for government have been identified as a way to help make sectors such as biopharma and Medtech more innovative and increase their value added.

Biopharma 77

Biopharma Competition Pharmaceutical Medicine 77

Fierce Pharma

JANUARY 23, 2023

Call for nominations: The most influential people in biopharma in 2023 esagonowsky Mon, 01/23/2023 - 14:32

Biopharma 130

Biopharma 130

Fierce Pharma

OCTOBER 24, 2023

In the biopharma industry, post-merger layoffs are often a question of when and how many. | In the biopharma industry, post-merger layoffs are often a question of when and how many. In the case of Amgen’s $27.8 billion buyout of Horizon, they came quickly.

Biopharma 269

Biopharma 269

European Pharmaceutical Review

AUGUST 14, 2023

The post Lilly completes biopharma acquisitions appeared first on European Pharmaceutical Review. The acquisition was completed on 11 August 2023. Biogen to acquire rare disease drugmaker for $7.3b

Biopharma 80

Biopharma Pharmaceutical Medicine Patients 80

Fierce Pharma

SEPTEMBER 7, 2023

Biopharma M&A is on an uptick compared to the post-pandemic doldrums of the last two years. Biopharma M&A is on an uptick compared to the post-pandemic doldrums of the last two years. Analysts anticipate that the trend will continue in 2023 and into 2024 as companies attempt to beef up their portfolios.

Biopharma 309

Biopharma Pharma 309

European Pharmaceutical Review

AUGUST 21, 2023

Q2 2023 biopharma market capitalisation results Eli Lilly “Eli Lilly witnessed the largest market capitalisation growth of 36.1 Lilly completes biopharma acquisitions GlobalData highlighted that Eli Lilly reported its synthetic peptide Mounjaro had $980 million in global sales in Q2. trillion in the Q1 of 2023 to $3.56

Biopharma 74

Biopharma Marketing Medicine FDA 74

Pharmaceutical Technology

FEBRUARY 28, 2023

Breakthroughs in therapies containing monoclonal antibodies (mAbs) are showing ever-greater potential in treating a range of diseases, alongside biopharma manufacturers facing the challenge of keeping up with demand for production while controlling costs. This can result in reductions in costs for our customers.” Download to learn more.

Biopharma 94

Biopharma Manufacturing Training Pharmaceutical 94

Fierce Pharma

NOVEMBER 27, 2023

It was the second straight quarter where the overwhelming success of blood sugar regulating treatments were the dominant story in the biopharma industry. Eli Lilly’s fortunes have turned quickly. | Eli Lilly and Novo Nordisk delivered the highest revenue gains, at 38% and 29%, respectively.

Biopharma 265

Biopharma Pharma 265

Fierce Pharma

NOVEMBER 22, 2022

2023 preview: Despite Biden's drug pricing win, the biopharma industry is not 'anywhere near done with this conversation'. esagonowsky. Tue, 11/22/2022 - 14:22.

Biopharma 130

Biopharma 130

MedCity News

JULY 31, 2023

Biopharma companies are harnessing AI tools for multiple aspects of drug development such as identifying drug development targets, modeling a drug’s effect on the body, and more.

Biopharma 81

Biopharma 81

Pharmaceutical Technology

NOVEMBER 14, 2023

With demand for drug products high, biopharma will need bold strategies to address sustainability challenges of the future.

Biopharma 52

Biopharma 52

PharmaTech

JUNE 1, 2023

A partnership between Rentschler Biopharma and Ikarovec will support the accelerated development of novel gene therapies for the treatment of eye diseases.

Biopharma 98

Biopharma 98

European Pharmaceutical Review

JUNE 8, 2023

A new report by the Association of the British Pharmaceutical Industry (ABPI) has identified the UK biopharma industry is increasingly seeking talent with artificial intelligence (AI) and data skills to maintain competitiveness as digital technology continues to drive innovation. This has spiked from 27 in 2019 to 225 in 2022.

Biopharma 73

Biopharma Pharmaceutical Pharma Government 73

MedCity News

MAY 9, 2023

Baxter International is selling its biopharma solutions business to private equity firms. The transaction is part of a broader trend in which life science firms are spinning out or selling operations in order to hone the focus of the remaining business on certain areas.

Biopharma 93

Biopharma Sales Pharma 93

PharmaVoice

MAY 23, 2023

These genetic advances could play a part in our biopharma future. Ancient DNA from a deer tooth. A new way to connect genes with disease. Biological super-computing.

Biopharma 98

Biopharma 98

Fierce Pharma

SEPTEMBER 5, 2023

Add Novartis to the list of biopharma giants that have filed lawsuits against the U.S. government as a reaction to the Inflation Reduction Act (IRA). | Add Novartis to the list of biopharma giants that have filed lawsuits against the U.S. government as a reaction to the Inflation Reduction Act.

Biopharma 272

Biopharma Government 272